Back
Halozyme Therapeutics Vs. Belite Bio Industry Stock Comparison
Buy
77
HALO
Halozyme Therapeutics
Last Price:
$59.15
Seasonality Move:
4.09%
Sell
35
BLTE
Belite Bio
Last Price:
$57.65
Seasonality Move:
-14.78%
Buy
77
Halozyme Therapeutics (HALO)
is a Buy
Is Halozyme Therapeutics a Buy, Sell or Hold?
-
The current Halozyme Therapeutics [HALO] share price is $59.14. The Score for HALO is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
HALO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Belite Bio (BLTE)
is a Sell
Is Belite Bio a Buy, Sell or Hold?
-
The current Belite Bio [BLTE] share price is $57.28. The Score for BLTE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
BLTE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HALO Stock Price Chart
What is Halozyme Therapeutics's stock price today?
-
The Halozyme Therapeutics share price today is $59.14Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HALO is experiencing buying pressure, which is a positive indicator for future bullish movement.
BLTE Stock Price Chart
What is Belite Bio's stock price today?
-
The Belite Bio share price today is $57.28The current trend is relatively stagnant and BLTE is experiencing buying pressure, which is a positive indicator for future bullish movement.
HALO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.09 | Buy |
Relative Strength Index (14 RSI): | 67.34 | Buy |
Chaikin Money Flow: | 1203801 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (56.3 - 58.2) | Buy |
Bollinger Bands (100): | (48.31 - 57.53) | Buy |
BLTE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.64 | Sell |
Relative Strength Index (14 RSI): | 49.53 | Sell |
Chaikin Money Flow: | 36225 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (55.88 - 58.6) | Buy |
Bollinger Bands (100): | (54.3 - 71.74) | Sell |
HALO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.95 | Buy |
20-day SMA: | 57.6 | Buy |
50-day SMA: | 53.83 | Buy |
200-day SMA: | 53.38 | Buy |
8-day EMA: | 58.08 | Buy |
20-day EMA: | 57.29 | Buy |
50-day EMA: | 55.23 | Buy |
200-day EMA: | 51.85 | Buy |
BLTE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 56.64 | Buy |
20-day SMA: | 56.98 | Buy |
50-day SMA: | 58.64 | Sell |
200-day SMA: | 55.49 | Buy |
8-day EMA: | 56.68 | Buy |
20-day EMA: | 57 | Buy |
50-day EMA: | 58.84 | Sell |
200-day EMA: | 55.58 | Buy |
Halozyme Therapeutics Earnings Growth & HALO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.34 per share, an increase next quarter of $0.01 per share, an increase this year of $0.80 per share, and an increase next year of $1.52 per share.
Belite Bio Earnings Growth & BLTE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and an increase next year of $0.65 per share.
Halozyme Therapeutics Technical Analysis
Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Belite Bio Technical Analysis
Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |